IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Wolf-Rudiger Press

USPTO Granted Patents = 12

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal11 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 1 
 
Schering Aktiengellsellschaft
 patent

Years Active: 1994-2001

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6254850 - Metal complexes, suitable for use in diagnosis and therapy (2001-07-03),
2. 6040432 - Metal complexes, of DTPA derivatives suitable for use in diagnosis and (2000-03-21),
3. 5980864 - 1,4,7,10-tetraazacyclododecane butyltriols, processes for their (1999-11-09),
4. 5885548 - Multiply substituted DTPA derivatives and their metal complexes, and (1999-03-23),
5. 5871709 - Macrocyclic compounds as complexing compounds or agents, complexes of (1999-02-16),
6. 5853699 - Use of tetra azacycle complexes as x-ray diagnostic agents for the liver (1998-12-29),
7. 5756066 - Iodine-containing peptides (1998-05-26),
8. 5746995 - DTPA derivatives substituted in a novel way, their metal complexes, and (1998-05-05),
9. 5672335 - Use of metal complexes as liver and gallbladder X-ray diagnostic agents (1997-09-30),
10. 5403572 - Macrocyclic polyaza compounds containing 5 or 6 membered rings, process (1995-04-04),
11. 5334371 - Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, (1994-08-02),
12. 5277895 - Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives, process (1994-01-11),

Title: Innovator Wolf-Rudiger Press: Pioneering Medical Advancements

Introduction: Wolf-Rudiger Press is a distinguished inventor based in Berlin, Germany, known for his significant contributions to the field of medical diagnostics and therapy. With an impressive portfolio of 12 patents to his name, Press has dedicated his career to innovating metal complexes that have potential applications in pharmaceuticals.

Latest Patents: Among his most notable inventions are two related patents concerning metal complexes that are suitable for use in diagnosis and therapy. The first patent details diethylenetriaminepentaacetic acid (DTPA) derivatives and their complexes, which contain elements with atomic numbers ranging from 20-32, 39-51, or 57-83. These compounds serve as pharmaceutical agents, with uses in contrast media and antidotes, alongside a detailed process for their production. The second patent reiterates similar innovations in DTPA derivatives, emphasizing their pharmaceutical utility in medical applications.

Career Highlights: Throughout his career, Wolf-Rudiger Press has made strides in the pharmaceutical industry, primarily working with well-known organizations. He was associated with Schering Aktiengesellschaft, a leading pharmaceutical company, where his research and innovations in metal complexes elevated the standard of diagnostic aids and therapeutics.

Collaborations: Press has worked alongside notable colleagues, including Werner Krause and Ulrich Speck. These collaborations have been instrumental in advancing research and furthering innovations in medical sciences.

Conclusion: Wolf-Rudiger Press stands out as a prominent inventor whose work has significantly impacted the field of diagnosis and therapy. His continued contributions to the development of metal complexes demonstrate his commitment to enhancing medical practices and improving patient care. His legacy lives on through his patents and the ongoing research inspired by his innovative spirit.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…